NCT05083416View on ClinicalTrials.gov

Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

October 20, 2021

Primary Completion Date

March 31, 2023

Study Completion Date

February 8, 2024

Conditions
Head and Neck Cancer
Interventions
BEHAVIORAL

Prolonged Nightly Fasting

Limiting daily period of food intake to 10 hours and nightly fasting period to 14 hours.

BEHAVIORAL

Regular Eating pattern

Food intake not limited to a specific time during day/night.

Trial Locations (1)

33612

Moffitt Cancer Center, Tampa

All Listed Sponsors
collaborator

American Cancer Society, Inc.

OTHER

lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT05083416 - Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome | Biotech Hunter | Biotech Hunter